Immunization of non-Hodgkin lymphoma patients with a novel recombinant idiotype vaccine: Results from a phase I clinical trial

被引：0
|
作者：
Bertinetti, C [1 ]
Dierbach, H [1 ]
Mauerer, K [1 ]
Mikesch, K [1 ]
Veelken, H [1 ]
机构：
[1] Univ Freiburg, Med Ctr, Dept Hematol Oncol, D-7800 Freiburg, Germany
来源：
EXPERIMENTAL HEMATOLOGY | 2005年 / 33卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
78
引用
收藏
页码：57 / 57
页数：1
相关论文
共 50 条
  • [31] A phase I trial of bortezomib in combination with everolimus for treatment of relapsed/refractory non-Hodgkin lymphoma
    Hill, Brian T.
    Smith, Mitchell R.
    Shelley, Meredeth
    Jagadeesh, Deepa
    Dean, Robert M.
    Pohlman, Brad
    Sweetenham, John W.
    Bolwell, Brian J.
    Smith, Stephen D.
    LEUKEMIA & LYMPHOMA, 2018, 59 (03) : 690 - 694
  • [32] Phase I/II trial of clofarabine in refractory and/or relapsed non-Hodgkin's lymphoma (NHL)
    Nabhan, C.
    Fried, W.
    Galvez, A.
    Venugopal, P.
    Bitran, J. D.
    ANNALS OF ONCOLOGY, 2008, 19 : 243 - 243
  • [33] Phase I/II trial of clofarabine in refractory and/or relapsed non-hodgkin's lymphoma (NHL)
    Nabhan, C.
    Fried, W.
    Galvez, A.
    Venugopal, P.
    Gozun, P.
    Bitran, J. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [34] Dendritic Cell Vaccine Treatment for B-Cell Non-Hodgkin Lymphoma: Clinical Trial in Progress
    Lin, Yi
    Atwell, Thomas
    Weisbrod, Adam
    Maas, Mary
    Armstrong, Adam S.
    Deeds, Michael
    Bulur, Peggy A.
    Gustafson, Michael
    Zhang, Zhe
    Cordes, Stefan
    Porrata, Luis F.
    Markovic, Svetomir N.
    Johnston, Patrick B.
    Micallef, Ivana N.
    Inwards, David J.
    Colgan, Joseph P.
    Ansell, Stephen M.
    Gastineau, Dennis A.
    Dietz, Allan B.
    Witzig, Thomas E.
    BLOOD, 2014, 124 (21)
  • [35] Recombinant methionyl human stem cell factor and filgrastim for peripheral blood progenitor cell mobilization and transplantation in non-Hodgkin's lymphoma patients - Results of a phase I/II trial
    Moskowitz, CH
    Stiff, P
    Gordon, MS
    McNiece, I
    Ho, AD
    Costa, JJ
    Broun, ER
    Bayer, RA
    Wyres, M
    Hill, J
    JelacaMaxwell, K
    Nichols, CR
    Brown, SL
    Nimer, SD
    Gabrilove, J
    BLOOD, 1997, 89 (09) : 3136 - 3147
  • [36] Idiotype vaccine therapy (BiovaxID) in follicular lymphoma in first complete remission: Phase III clinical trial results
    Schuster, S. J.
    Neelapu, S. S.
    Gause, B. L.
    Muggia, F. M.
    Gockerman, J. P.
    Sotomayor, E. M.
    Winter, J. N.
    Flowers, C. R.
    Stergiou, A. M.
    Kwak, L. W.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [37] Efficacy and effectiveness of the influenza vaccine in patients with Hodgkin's and non-Hodgkin's lymphoma
    Mazza, JJ
    Yale, SH
    Reynolds, CE
    Glurich, I
    Po-Huang, C
    Kurt, RD
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2005, 20 : 185 - 185
  • [38] Phase II clinical trial of interleukin-12 in patients with relapsed and refractory non-Hodgkin's lymphoma and Hodgkin's disease
    Younes, A
    Pro, B
    Robertson, MJ
    Flinn, IW
    Romaguera, JE
    Hagemeister, F
    Dang, NH
    Fiumara, P
    Loyer, EM
    Cabanillas, FF
    McLaughlin, PW
    Rodriguez, MA
    Samaniego, F
    CLINICAL CANCER RESEARCH, 2004, 10 (16) : 5432 - 5438
  • [39] Idiotype vaccine therapy (BiovaxID) in follicular lymphoma in first complete remission: Phase III clinical trial results
    Schuster, S. J.
    Neelapu, S. S.
    Gause, B. L.
    Muggia, F. M.
    Gockerman, J. P.
    Sotomayor, E. M.
    Winter, J. N.
    Flowers, C. R.
    Stergiou, A. M.
    Kwak, L. W.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (18)
  • [40] ePharmacodynamic Biomarkers of Mosunetuzumab Efficacy and Safety in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma: Results from a Phase I/II Study
    Huw, Ling-Yuh
    Li, Feifei
    Belousov, Anton
    Ramesha, Hemanth
    Bolen, Christopher R.
    Wei, Michael C.
    Yin, Shen
    Turner, David C.
    Penuel, Elicia
    BLOOD, 2022, 140 : 6448 - 6449
12345